Premium
Worse quality of life in volunteer blood donors with hepatitis C
Author(s) -
Dias Teixeira Maria Cristina,
De Sá Ribeiro Maria de Fátima Gomes,
Gayotto Luis Carlos da Costa,
Chamone Dalton de Alencar Fischer,
Strauss Edna
Publication year - 2006
Publication title -
transfusion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.045
H-Index - 132
eISSN - 1537-2995
pISSN - 0041-1132
DOI - 10.1111/j.1537-2995.2006.00712.x
Subject(s) - medicine , hepatitis c virus , hepatitis c , volunteer , liver disease , liver biopsy , quality of life (healthcare) , population , ribavirin , gastroenterology , alcoholic liver disease , cirrhosis , immunology , biopsy , virus , nursing , environmental health , agronomy , biology
BACKGROUND: Health‐related quality of life (HRQOL) encompasses many different aspects of health perceived by the individual, and its alterations in patients with hepatitis C virus (HCV) have been recently reported. The objective was to study a population of volunteer blood donors at different stages of HCV liver disease. STUDY DESIGN and METHODS: The Medical Outcomes Study 36‐Item Short‐Form Health Survey (SF‐36), a generic tool, was used to evaluated HRQOL. The SF‐36 scores of HCV patients were compared with those of matched healthy blood donors and at the sixth month in those who were submitted to antiviral treatment. Sex, drug use, and alcohol consumption were also evaluated. A total of 120 HCV chronic carriers were divided into three groups: 1) patients with no indication for liver biopsy (n = 37); 2) patients submitted to liver biopsy with mild liver disease (n = 40); and 3) patients with moderate to severe liver disease submitted to interferon plus ribavirin treatment (n = 43). RESULTS: HCV patients had significantly lower SF‐36 scores when compared with matched healthy blood donors. There was no correlation between SF‐36 scores and history of intravenous and/or inhaled drug use or alcohol consumption. Women had lower SF‐36 scores than men in six domains. At the sixth month of treatment, patients who continued to be positive for the presence of HCV RNA (nonresponders) had lower quality of life than those who became HCV RNA–negative. CONCLUSION: Healthy blood donors with HCV showed significantly reduced HRQOL that was more marked in women. The presence of the virus is one of the possible explanations for the reduced HRQOL.